Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 10-day trial to continue exploring with full access.

The compliance side of the war on drugs

Jaclyn Jaeger | July 21, 2017

Pharmaceutical manufacturers and distributors increasingly are being called for duty in the nationwide war on drugs, particularly in covert operations where the government believes those in the corporate supply chain have crept over enemy lines.

“In the midst of one of the worst drug abuse crises in American history, the Department of Justice has the responsibility to ensure that our drug laws are being enforced,” Attorney General Jeff Sessions said in a statement. “Part of that mission is holding drug manufacturers accountable for their actions.”

In a first-of-its-kind case that highlights the government’s broadening enforcement stance to conquer the nationwide opioid epidemic, Mallinckrodt Pharmaceuticals—a maker of generic oxycodone—on July 11 reached a $35 million settlement with the government to resolve allegations that the pharmaceutical manufacturer failed to report suspicious orders of pharmaceutical drugs, and for record-keeping violations.

... To get the full story, subscribe now.